What Drove CME’s Revenue And EBITDA Growth In 2015?

+5.77%
Upside
215
Market
228
Trefis
CME: CME Group logo
CME
CME Group

CME witnessed a 7% year-on-year (y-o-y) rise in its revenues in 2015, primarily due to higher energy contract and foreign exchange contract trading revenue. On the other hand, the company’s expenses increased 1% y-o-y, owing to foreign currency translation losses. The brokerage’s EBITDA increased 11% on a year on year basis and its EBITDA margin expanded by 340 basis points.

ff1

Relevant Articles
  1. Up 26% YTD, What’s Next For CME Group Stock?
  2. What To Expect From CME Group Stock?
  3. What To Expect From CME Group Stock?
  4. CME Group Stock To Top The Street Expectations In Q4
  5. What To Expect From CME Group Stock?
  6. CME Group Stock To Beat The Street Expectations In Q3?

ff2

Have more questions about CME? See the links below:

Notes:

1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment / ask questions on the comments section
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to the full Trefis analysis for CME Group.

View Interactive Institutional Research (Powered by Trefis):
Global Large CapU.S. Mid & Small CapEuropean Large & Mid Cap
More Trefis Research